
Mitchell Steiner
Advertisement
Articles by Mitchell Steiner


Advertisement
Latest Updated Articles
7 TiP Randomized, Multicenter, International Phase 3 ARTEST Study to Evaluate the Efficacy and Safety of Enobosarm Versus Active Control for the Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Previously Received an Estrogen-Blocking Agent and CDK4/6 InhibitorPublished: April 18th 2022 | Updated:
8 TiP Randomized, Multicenter, Phase 3 Study to Evaluate the Combination of Enobosarm and Abemaciclib Compared With Estrogen-Blocking Agent for the Second-Line Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Have Previously Received Palbociclib and an Estrogen-Blocking Agent Combination TherapyPublished: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
SABCS 2025: The Top 5 Takeaways for Breast Cancer Research
2
FDA Approves Subcutaneous Mosunetuzumab in R/R Follicular Lymphoma
3
Pyrotinib Combo Sustains Survival Benefits in HER2+ Breast Cancer Trial
4
Novel Anti-BCMA Agent Shows Preliminary Responses in R/R Multiple Myeloma
5

